- Advertisement -

Over 4% of summer mortality in European cities is attributable to urban heat islands

Over four percent of deaths in cities during the summer months are due to urban heat islands, and one third of these deaths could...

Doubling Up on Single Cell

The collaboration aims to help biopharmas accelerate their drug discovery and development efforts by uncovering biomarkers and generating insights to distill the data into...

Optimizing AAV and Lentiviral Vector Development

Sponsored content brought to you by Plasmids are essential for the development of viral vectors used to manufacture novel gene therapies and viral vaccines. Aldevron...

Unusual partners aid blood vessel growth

AUGUSTA, Ga. (March 8, 2022) – Insufficient oxygen to an area like the heart or legs, called hypoxia, is a cue to our bodies to...

Moderna’s coronavirus vaccine candidate shows promise in phase I trial

The world is one small step closer to having a vaccine against the novel coronavirus as Moderna, a U.S. based biotechnology firm, announced promising...

Key Insights into Overcoming mRNA Process Challenges

Sponsored content brought to you by As the COVID-19 pandemic began to wreak havoc on the world in 2020, the biopharmaceutical industry started working tirelessly...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

See, Blind Mice: Consortium’s Drugs Restore Sight

A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

See, Blind Mice: Consortium’s Drugs Restore Sight

A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in...

Protein Design’s AI Revolution: Inside David Baker’s “Communal Brain”

“I have this idea of a communal brain.” David Baker, PhD, told me as I sat in his office at the University of Washington...

more new items

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

See, Blind Mice: Consortium’s Drugs Restore Sight

A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in...

Protein Design’s AI Revolution: Inside David Baker’s “Communal Brain”

“I have this idea of a communal brain.” David Baker, PhD, told me as I sat in his office at the University of Washington...